Author

Evan T. Ogburn

Observed names: E Ogburn, E T Ogburn, Evan Ogburn, Evan T Ogburn, Ogburn, Evan T.

Observed institutions: University of North Carolina at Chapel Hill, Duke University, East Carolina University, International Breast Cancer Research Foundation, Indiana University Bloomington, Indiana University Indianapolis, Indiana University School of Medicine, University of Cincinnati

OpenAlex ID: A5113610571

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

2011 · William J. Irvin, Christine M. Walko, et al. · Journal of Clinical Oncology · 181

Efavirenz Primary and Secondary Metabolism In Vitro and In Vivo: Identification of Novel Metabolic Pathways and Cytochrome P450 2A6 as the Principal Catalyst of Efavirenz 7-Hydroxylation

2010 · Evan T. Ogburn, David R. Jones, et al. · Drug Metabolism and Disposition · 156

Stereoselective and regiospecific hydroxylation of ketamine and norketamine

2012 · Zeruesenay Desta, Ruin Moaddel, et al. · Xenobiotica · 114

Citalopram and escitalopram plasma drug and metabolite concentrations: genome‐wide associations

2014 · Yuan Ji, Daniel J. Schaid, et al. · British Journal of Clinical Pharmacology · 83

In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole

2010 · Landry K. Kamdem, Yong Liu, et al. · British Journal of Clinical Pharmacology · 79

Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo

2012 · Cong Xu, Evan T. Ogburn, et al. · Drug Metabolism and Disposition · 70

Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers

2012 · V Michaud, E Ogburn, et al. · Clinical Pharmacology & Therapeutics · 46

Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo

2012 · H E Meyer zu Schwabedissen, S Oswald, et al. · Clinical Pharmacology & Therapeutics · 43

Impact of Efavirenz on Intestinal Metabolism and Transport: Insights From an Interaction Study With Ezetimibe in Healthy Volunteers

2012 · S Oswald, H E Meyer zu Schwabedissen, et al. · Clinical Pharmacology & Therapeutics · 43

Contribution of N-Glucuronidation to Efavirenz EliminationIn Vivoin the Basal and Rifampin-Induced Metabolism of Efavirenz

2011 · Doo-Yeoun Cho, Evan T. Ogburn, et al. · Antimicrobial Agents and Chemotherapy · 36

CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer

2013 · Richard R Love, Zuerenesay Desta, et al. · SpringerPlus · 33

Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent

2013 · V Michaud, Y Kreutz, et al. · The Pharmacogenomics Journal · 20

Microfabricated Electrochemical Detector for High-Performance Liquid Chromatography

2011 · Evan T. Ogburn, Michael Dziewatkoski, et al. · Analytical Chemistry · 6

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

2020 · Weck, Karen E., Anderson, Steven M., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

Ox-PRiME - Oxford Primary trial Management Environment

2019 · David Dyson, Evan T. Ogburn, et al. · Trials

Characterization of a Microfabricated Electrochemical Detector and Coupling with High Performance Liquid Chromatography

2009 · Evan T. Ogburn · OhioLink ETD Center (Ohio Library and Information Network)

Works count: 17

Citation count: 910

H-index: 12

I10-index: 12